This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
Accepts major insurance plans—including Harvard Pilgrim Health Care, WellCare, MaineCare, Maine Community Health Options, and Amerigroup. Offers discounted self-pay rates and helps uninsured clients explore grant programs. Call the center at (888) 858-1723 to start your treatment journey today.
Just a 7-minute drive from the Colby College Museum of Art, this outpatient center sits near the Kennebec River and the historic Lockwood Mill District, offering accessible, community-rooted care for those navigating opioid use disorder. Since 2014, it has delivered comprehensive care through medication-assisted treatment (MAT), complemented by flexible virtual and in-person counseling. Open Monday through Thursday from 9:00 a.m. to 7:00 p.m., the center remains closed Friday through Sunday.
Patients receive evidence-based care, including cognitive behavioral therapy (CBT), motivational interviewing (MI), and the matrix model. These approaches address trauma, anger management, and relapse prevention to promote emotional stability and long-term recovery. Services also include substance use education, discharge planning, aftercare coordination, and sign language support for the deaf and hard of hearing.
The center provides FDA-approved suboxone to manage withdrawal symptoms and reduce cravings, complemented by weekly group therapy sessions. Clients receive personalized care from a supportive team including substance use counselors, recovery support specialists, and clinicians. Their intake specialists remain available 24/7 to answer questions and assist clients in scheduling appointments online at their convenience.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
CARF stands for the Commission on Accreditation of Rehabilitation Facilities. It's an independent, non-profit organization that provides accreditation services for a variety of healthcare services. To be accredited means that the program meets their standards for quality, effectiveness, and person-centered care.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT
Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.
Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.
Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.